Nearly 40% of Fluoroquinolone Antibiotic Days Unnecessary - Becker's Hospital Review

Study results showed approximately 40 percent of all patient days of fluoroquinolone antibiotics are unnecessary, according to a study published in BMJ Infectious Diseases.

Read the full report in Becker’s ASC Review on fluoroquinolone antibiotics.

Next Up in Clinical Leadership & Infection Control

CDC's No. 2 leader resigns after 3 months

Ralph Abraham, MD, principal deputy director of the CDC, has resigned after three months in the role. Dr. Abraham stepped…

'The best ideas come from the front lines': Why Penn State Health's CEO still practices medicine

When Michael Kupferman, MD, became CEO of Hershey, Pa.-based Penn State Health in late June 2025, he brought a special…

AAP updates pediatric anesthesia policy

The American Academy of Pediatrics has revised its policy statement on facility-based requirements for pediatric anesthesia. The AAP last updated…

The Future of Healthcare Leadership: Risks, Realities, and Readiness for 2026

Next Up in Clinical Leadership & Infection Control

CDC's No. 2 leader resigns after 3 months

'The best ideas come from the front lines': Why Penn State Health's CEO still practices medicine

AAP updates pediatric anesthesia policy

Join the 500,000+ healthcare executives who start their day with Becker’s